Search Results - "VEEDER, M. H"

Refine Results
  1. 1

    Prospective evaluation of vitamin E for hot flashes in breast cancer survivors by Barton, D L, Loprinzi, C L, Quella, S K, Sloan, J A, Veeder, M H, Egner, J R, Fidler, P, Stella, P J, Swan, D K, Vaught, N L, Novotny, P

    Published in Journal of clinical oncology (01-02-1998)
    “…Hot flashes represent a substantial clinical problem for some breast cancer survivors. Although estrogen or progesterone preparations can alleviate these…”
    Get more information
    Journal Article
  2. 2

    Transdermal clonidine for ameliorating tamoxifen-induced hot flashes by Goldberg, R M, Loprinzi, C L, O'Fallon, J R, Veeder, M H, Miser, A W, Mailliard, J A, Michalak, J C, Dose, A M, Rowland, Jr, K M, Burnham, N L

    Published in Journal of clinical oncology (01-01-1994)
    “…To determine the efficacy of transdermal clonidine for alleviating tamoxifen-induced hot flashes in women with a history of breast cancer. A randomized,…”
    Get more information
    Journal Article
  3. 3

    Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer by Moertel, C G, Fleming, T R, Macdonald, J S, Haller, D G, Laurie, J A, Tangen, C M, Ungerleider, J S, Emerson, W A, Tormey, D C, Glick, J H

    Published in Journal of clinical oncology (01-12-1995)
    “…To determine the effectiveness of fluorouracil plus levamisole administered postoperatively to patients with resected stage II (Dukes' B2) colon cancer. This…”
    Get more information
    Journal Article
  4. 4

    Inhibition of fluorouracil-induced stomatitis by oral cryotherapy by Mahood, D J, Dose, A M, Loprinzi, C L, Veeder, M H, Athmann, L M, Therneau, T M, Sorensen, J M, Gainey, D K, Mailliard, J A, Gusa, N L

    Published in Journal of clinical oncology (01-03-1991)
    “…Mucositis is a significant dose-limiting toxicity associated with fluorouracil (5FU), particularly when it is combined with leucovorin. We hypothesized that…”
    Get more information
    Journal Article
  5. 5

    Phase III Clinical Trial of the Combination of Cisplatin, Dacarbazine, and Carmustine With or Without Tamoxifen in Patients With Advanced Malignant Melanoma by CREAGAN, E. T, SUMAN, V. J, DALTON, R. J, PITOT, H. C, LONG, H. J, VEEDER, M. H, VUKOV, A. M, ROWLAND, K. M, KROOK, J. E, MICHALAK, J. C

    Published in Journal of clinical oncology (01-06-1999)
    “…A prospective randomized phase III clinical trial was conducted to assess whether the addition of tamoxifen (TAM) to the three-agent regimen of cisplatin…”
    Get full text
    Journal Article
  6. 6

    A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma by Ingle, James N., Suman, Vera J., Kardinal, Carl G., Krook, James E., Mailliard, James A., Veeder, Michael H., Loprinzi, Charles L., Dalton, Robert J., Hartmann, Lynn C., Conover, Cheryl A., Pollak, Michael N.

    Published in Cancer (15-03-1999)
    “…BACKGROUND Tamoxifen (TAM) is generally considered the hormonal agent of choice for postmenopausal women with hormone receptor positive breast carcinoma. The…”
    Get full text
    Journal Article
  7. 7

    Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial by Maksymiuk, A W, Jett, J R, Earle, J D, Su, J Q, Diegert, F A, Mailliard, J A, Kardinal, C G, Krook, J E, Veeder, M H, Wiesenfeld, M

    Published in Journal of clinical oncology (01-01-1994)
    “…The combination of etoposide (E) and cisplatin (P) is an accepted standard therapy for small-cell lung cancer (SCLC); however, the optimal sequencing and…”
    Get more information
    Journal Article
  8. 8

    Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer by Camoriano, J K, Loprinzi, C L, Ingle, J N, Therneau, T M, Krook, J E, Veeder, M H

    Published in Journal of clinical oncology (01-08-1990)
    “…Six hundred forty-six women with node-positive breast cancer from two prospective, randomized, adjuvant breast cancer trials were evaluated for changes in…”
    Get more information
    Journal Article
  9. 9

    A prospective study of pulmonary function in patients receiving mitomycin by Castro, M, Veeder, M H, Mailliard, J A, Tazelaar, H D, Jett, J R

    Published in Chest (01-04-1996)
    “…Mitomycin is a chemotherapeutic agent that is used to treat a variety of solid tumors. Pulmonary toxic reactions from this agent can be life threatening. We…”
    Get more information
    Journal Article
  10. 10

    Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report by Moertel, C G, Fleming, T R, Macdonald, J S, Haller, D G, Laurie, J A, Tangen, C M, Ungerleider, J S, Emerson, W A, Tormey, D C, Glick, J H, Veeder, M H, Mailliard, J A

    Published in Annals of internal medicine (01-03-1995)
    “…To determine the effectiveness of two adjuvant therapy regimens in improving surgical cure rates in stage III (Dukes stage C) colon cancer. Randomized,…”
    Get full text
    Journal Article
  11. 11

    A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinoma by Creagan, E T, Twito, D I, Johansson, S L, Schaid, D J, Johnson, P S, Flaum, M A, Buroker, T R, Geeraerts, L H, Veeder, M H, Gesme, Jr, D H

    Published in Journal of clinical oncology (01-12-1991)
    “…We performed a prospective, controlled trial of recombinant leukocyte A interferon (IFN-alpha 2A) with or without aspirin (ASA) in 176 patients with assessable…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: a study of the North Central Cancer Treatment group by Goldberg, R M, Jett, J R, Therneau, T M, Johnson, P S, Tschetter, L K, Krook, J E, Veeder, M H, Owen, D, Etzell, P S, Andres, D F

    “…In an effort to test clinically the hypothesis that the duration of cellular exposure to etoposide (VP-16) and cisplatin (CDDP) is an important determinant of…”
    Get more information
    Journal Article
  14. 14

    Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor by CASCINO, T. L, VEEDER, M. H, BUCKNER, J. C, O'FALLON, J. R, WIESENFELD, M, LEVITT, R, GOLDBERG, R. M, KUROSS, S. A, MORTON, R. F, SCHEITHAUER, B. W

    Published in Journal of neuro-oncology (01-12-1996)
    “…Thirty patients with recurrent primary brain tumors were treated with a combination of 5-fluorouracil and leucovorin. There were three responses seen. Toxicity…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenocarcinoma by CREAGAN, E. T, VEEDER, M. H, SUMAN, V. J, BURCH, P. A, MAPLES, W. J, SCHAEFER, P. L, PFEIFLE, D. M, DALTON, R. J, HATFIELD, A. K, POON, M. A

    Published in American journal of clinical oncology (01-10-1998)
    “…Cimetidine is an H2-receptor antagonist used in the management of peptic ulcer disease and other hypersecretory gastrointestinal disorders. This agent has…”
    Get full text
    Journal Article
  17. 17

    Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer by Ingle, J N, Foley, J F, Mailliard, J A, Krook, J E, Hartmann, L C, Jung, S H, Veeder, M H, Gesme, Jr, D H, Hatfield, A K, Goldberg, R M

    Published in Cancer (01-05-1994)
    “…The fraction of breast cancer cells undergoing DNA synthesis at any one time is relatively low, which is problematic because most chemotherapeutic agents are…”
    Get more information
    Journal Article
  18. 18

    A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma by Veeder, M H, Jett, J R, Su, J Q, Mailliard, J A, Foley, J F, Dalton, R J, Etzell, P S, Marschke, Jr, R F, Kardinal, C G, Maksymiuk, A W

    Published in Cancer (01-11-1992)
    “…In an effort to confirm the efficacy of mitomycin C against metastatic squamous cell lung carcinoma and to compare the efficacy of single-agent therapy with a…”
    Get more information
    Journal Article
  19. 19

    Phase II Trial of Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced/Recurrent Endometrial Carcinoma by Long, Harry J., Langdon, Robert M., Cha, Stephen S., Veeder, Michael H., Pfeifle, Delano M., Krook, James E., Ebbert, Larry P., Tschetter, Loren K., Roshon, Steven G.

    Published in Gynecologic oncology (01-08-1995)
    “…A phase II combination chemotherapy protocol combining methotrexate, vinblastine, doxorubicin, and cisplatin was designed to evaluate tumor response and…”
    Get full text
    Journal Article
  20. 20

    Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancer by INGLE, J. N, KARDINAL, C. G, SUMAN, V. J, VEEDER, M. H, SCHAEFER, P. L, KIRSCHLING, R. J, MAILLIARD, J. A

    Published in Breast cancer research and treatment (01-05-1997)
    “…Based on reports of substantial antitumor efficacy of the combination of mitoxantrone (DHAD), 5-fluorouracil (FU) and leucovorin (LV), a clinical trial was…”
    Get full text
    Journal Article